SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004065
Filing Date
2021-11-10
Accepted
2021-11-10 16:02:52
Documents
81
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fstx-20210930.htm   iXBRL 10-Q 2490077
2 EX-10.2 fstx-ex10_2.htm EX-10.2 626360
3 EX-10.3 fstx-ex10_3.htm EX-10.3 1028251
4 EX-31.1 fstx-ex31_1.htm EX-31.1 19901
5 EX-31.2 fstx-ex31_2.htm EX-31.2 19640
6 EX-32.1 fstx-ex32_1.htm EX-32.1 10987
7 EX-32.2 fstx-ex32_2.htm EX-32.2 11003
  Complete submission text file 0000950170-21-004065.txt   11572484

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fstx-20210930_def.xml EX-101.DEF 277612
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fstx-20210930_cal.xml EX-101.CAL 57374
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fstx-20210930.xsd EX-101.SCH 63180
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fstx-20210930_lab.xml EX-101.LAB 558483
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fstx-20210930_pre.xml EX-101.PRE 434150
13 EXTRACTED XBRL INSTANCE DOCUMENT fstx-20210930_htm.xml XML 1856093
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 211396452
SIC: 2834 Pharmaceutical Preparations